Business Context and Reporting Period
This Form 8-K was filed by Ingevity Corporation on April 26, 2016. The report covers preliminary financial results for the quarter ended March 31, 2016, and provides fiscal year 2016 guidance. The filing is issued in advance of the anticipated spin-off of Ingevity from WestRock Company, which is targeted for May 15, 2016.
Key Financial Metrics
The filing text references preliminary financial results for the quarter ended March 31, 2016, and fiscal year 2016 guidance, but does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity within the body of this report. These metrics are contained in attached Exhibit 99.1. Similarly, historical financial information for fiscal years 2015 and 2014 is referenced in Exhibit 99.2 but not detailed in this text.
Material Changes and Corporate Events
- Spin-off Preparation: Ingevity is preparing for separation from WestRock Company, with a target date of May 15, 2016.
- Investor Materials: WestRock has prepared investor presentation slides for use in discussions regarding the spin-off, available on Ingevity's website.
- EBITDA Reconciliation: A reconciliation of WestRock's Specialty Chemicals division adjusted EBITDA to Ingevity's adjusted EBITDA is provided in Exhibit 99.3.
Guidance, Outlook, and Risks
The filing includes forward-looking statements regarding the expected timing of the separation from WestRock Company. Management cautions that actual results could differ materially from these projections due to various risks and uncertainties. The filing explicitly states that the information contained in Items 2.02 and 7.01, including the exhibits, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 for specific preliminary financial results for Q1 2016 and full-year 2016 guidance.
- Examine Exhibit 99.2 for historical quarterly financial data for fiscal years 2014 and 2015.
- Analyze Exhibit 99.3 to understand the reconciliation of adjusted EBITDA between WestRock's division and the standalone Ingevity entity.
- Verify the status of the spin-off transaction and the May 15, 2016 target date via the investor presentation in Exhibit 99.4.
- Consult the Form 10 Registration Statement for a detailed description of risks affecting the business and forward-looking statements.